Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Tuesday, April 23, 2019  Spokane, Washington  Est. May 19, 1883
Partly Cloudy Night 55° Partly Cloudy
News >  WA Government

Senate votes to raise legal age to purchase tobacco, vaping products to 21

UPDATED: Wed., March 27, 2019, 7:10 p.m.

Sen. Mike Padden, R-Spokane Valley, argues Wednesday to let members of the military purchase tobacco products at age 18 during debate on a bill to raise the age to 21. The bill passed; Padden’s amendment failed. (Jim Camden / The Spokesman-Review)
Sen. Mike Padden, R-Spokane Valley, argues Wednesday to let members of the military purchase tobacco products at age 18 during debate on a bill to raise the age to 21. The bill passed; Padden’s amendment failed. (Jim Camden / The Spokesman-Review)

OLYMPIA – Washington residents who aren’t 21 by next New Year’s Day won’t be able to buy cigarettes or vaping products in the state.

But if they buy tobacco products from a tribal smoke shop or across the Idaho border, there will be no penalty for possessing or using them in the state.

On a 33-12 bipartisan vote, the Senate gave final approval Wednesday to a proposal to raise the age for purchasing tobacco products starting next year. Gov. Jay Inslee has said he will sign it, making Washington the ninth state to increase the age to 21.

“This bill is about saving lives,” said Sen. Patty Kuderer, D-Bellevue, who told of watching her grandfather die of emphysema. People who don’t smoke before they are 21 are less likely to start afterward, she said.

Sen. Ann Rivers, R-La Center, also told of losing her parents and an older sister to lung cancer. All started smoking at age 14 and later said if they knew the dangers, they never would have started. While Rivers voted for the bill, she said she was worried the state was setting up a “thriving black market” for tobacco and vaping products by not including penalties for possession of those products by people younger than 21.

The Senate rejected an amendment to add civil penalties to the bill for possession of tobacco or vaping products by those under 21. Sen. Doug Ericksen, R-Ferndale, argued that without those penalties, smoke shops on tribal land or close to cross-border cities will have an unfair advantage on nearby stores that have to follow state law.

“It’ll be great for Stateline, Idaho,” he added.

Kuderer said the Legislature could work on penalties in the future, but urged senators to reject them at this point: “This is a health care bill. It’s not about punishment.”

Also rejected was an amendment by Sen. Mike Padden, R-Spokane Valley, that would have allowed members of the military who are under 21 to purchase tobacco products.

“These folks that have served their country … and happen to be under 21, should have the choice to decide,” Padden said. While he would advise them not to smoke, it should be up to them or “the nanny state is alive and well.”

“The military has changed,” countered Sen. Steve Hobbs, D-Lake Stevens, and a major in the Washington National Guard. The physical fitness standards are getting tougher and “sometimes young soldiers make the wrong choices.”

Earlier in the day, the Legislature had passed resolutions honoring the Washington National Guard, and Kuderer cited a letter from Guard officials urging lawmakers to raise the age to smoke and mentioning tobacco use as one reason why only a fourth of all teens can meet the physical fitness requirements for enlistment.

Opposition to the bill included some of the Senate’s more conservative and liberal members. Sen. Jesse Salomon, D-Shoreline, joined Padden in the effort to allow military personnel to purchase tobacco products at 18.

Sen. Phil Fortunato, R-Auburn, said legislators should make up their minds when a person is an adult.

“Either you’re an adult at 18 or you’re not,” he said. “If they’re not going to make the right decision to smoke, why do we trust them to vote?”

Sen. Bob Hasegawa, D-Seattle, said he agreed with limiting tobacco, but not vaping products, which he contended are much safer, and some studies have concluded “there’s no evidence it’s a gateway drug.”

Subscribe to the Morning Review newsletter

Get the day’s top headlines delivered to your inbox every morning by subscribing to our newsletter.

You have been successfully subscribed!
There was a problem subscribing you to the newsletter. Double check your email and try again, or email webteam@spokesman.com